Aprameya Engineering Ltd vs Avience Biomedicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Aprameya Engineering Ltd is ₹ 89.9 as of 23 Oct 15:30 . The P/E Ratio of Aprameya Engineering Ltd is 12.1 as of March 2025 .The P/E Ratio of Avience Biomedicals Ltd is 0 as of March 2025 . The Market Cap of Aprameya Engineering Ltd is ₹ 194.97 crore as of March 2025 .The Market Cap of Avience Biomedicals Ltd is ₹ 0 crore as of March 2025 . The Dividend Payout of Aprameya Engineering Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aprameya Engineering Ltd

Aprameya Engineering Limited was originally formed as a partnership firm in the name and style of 'M/s.
Aprameya Engineering' pursuant to a Deed of Partnership dated September 05, 2003, registered as on August 13, 2004 at Ahmedabad.
Subsequently, Company incorporated pursuant to a Certificate of Incorporation dated December 28, 2021 issued by the Registrar of Companies, following the conversion of Partnership Firm 'M/s.
Aprameya Engineering' to a Private Limited Company.
Further, Company converted into a Public Limited Company and its name was changed from 'Aprameya Engineering Private Limited' to 'Aprameya Engineering Limited' vide a fresh Certificate of Incorporation upon conversion dated May 12, 2022, issued by the Registrar of Companies, Ahmedabad. Company is a trusted partner in India's healthcare infrastructure space, with over two decades of experience in delivering turnkey hospital projects and integrated medical technology solutions across public and private sectors.

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

FAQs for the comparison of Aprameya Engineering Ltd and Avience Biomedicals Ltd

Which company has a larger market capitalization, Aprameya Engineering Ltd or Avience Biomedicals Ltd?

Market cap of Aprameya Engineering Ltd is 171 Cr while Market cap of Avience Biomedicals Ltd is 131 Cr

What are the key factors driving the stock performance of Aprameya Engineering Ltd and Avience Biomedicals Ltd?

The stock performance of Aprameya Engineering Ltd and Avience Biomedicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aprameya Engineering Ltd and Avience Biomedicals Ltd?

As of October 24, 2026, the Aprameya Engineering Ltd stock price is INR ₹89.9. On the other hand, Avience Biomedicals Ltd stock price is INR ₹240.0.

How do dividend payouts of Aprameya Engineering Ltd and Avience Biomedicals Ltd compare?

To compare the dividend payouts of Aprameya Engineering Ltd and Avience Biomedicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.